Humana is a healthcare plans business based in the US. Humana shares (HUM) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $293.97 – an increase of 3.82% over the previous week. Humana employs 67,600 staff and has a trailing 12-month revenue of around $115 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $293.97 |
|---|---|
| 52-week range | $213.31 - $522.08 |
| 50-day moving average | $283.00 |
| 200-day moving average | $334.80 |
| Wall St. target price | $286.90 |
| PE ratio | 25.2578 |
| Dividend yield | $3.54 (1.22%) |
| Earnings per share (TTM) | $11.21 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $277.78 from 2024-11-19
| 1 week (2024-11-14) | -1.89% |
|---|---|
| 1 month (2024-10-21) | 6.60% |
| 3 months (2024-08-21) | -22.53% |
| 6 months (2024-05-21) | -21.89% |
| 1 year (2023-11-21) | -45.22% |
|---|---|
| 2 years (2022-11-21) | -46.21% |
| 3 years (2021-11-19) | 424.7909 |
| 5 years (2019-11-21) | 326.2402 |
Valuing Humana stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Humana's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Humana's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, Humana shares trade at around 25x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Humana's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3265. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Humana's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Humana's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.8 billion.
The EBITDA is a measure of a Humana's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $115 billion |
|---|---|
| Operating margin TTM | 2.66% |
| Gross profit TTM | $17.2 billion |
| Return on assets TTM | 4.01% |
| Return on equity TTM | 7.84% |
| Profit margin | 1.18% |
| Book value | $145.88 |
| Market Capitalization | $34.1 billion |
TTM: trailing 12 months
Dividend payout ratio: 19.41% of net profits
Recently Humana has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Humana shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Humana's case, that would currently equate to about $3.54 per share.
While Humana's payout ratio might seem low, this can signify that Humana is investing more in its future growth.
Humana's most recent dividend payout was on 30 January 2025. The latest dividend was paid out to all shareholders who bought their shares by 30 December 2024 (the "ex-dividend date").
Humana's shares were split on a 3:2 basis on 31 July 1991 . So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Humana shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Humana shares which in turn could have impacted Humana's share price.
Over the last 12 months, Humana's shares have ranged in value from as little as $213.31 up to $522.0805. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Humana's is 0.52. This would suggest that Humana's shares are less volatile than average (for this exchange).
Humana Inc. , together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties.
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.